Professor David Sharp is a neurologist and Centre Director of UK DRI Care Research & Technology, focusing on using technology to enhance the lives of people living with dementia. He is also Scientific Director of the Imperial College Clinical Imaging Facility and Associate Director of the Imperial Centre for Injury Studies. His research programme aims to improve clinical outcomes after dementia and traumatic brain injury (TBI), focusing on common cognitive impairments in domains such as memory and attention. He uses cognitive neuroscience and advanced neuroimaging to investigate the effect of brain injury on brain network function and the effects of inflammation and neurodegeneration. His has explored how new treatments of cognitive impairment can be personalised and his current work focuses on harnessing neurotechnology development to improve the lives of those living with dementia and the effects of brain injury.
et al., 2021, Player position in American Football influences the magnitude of mechanical strains produced in the location of chronic traumatic encephalopathy pathology: a computational modelling study, Journal of Biomechanics, Vol:118, ISSN:0021-9290
et al., 2021, Psychotropic and pain medication use in individuals with traumatic brain injury-a Swedish total population cohort study of 240 000 persons., J Neurol Neurosurg Psychiatry
et al., 2021, High rates of SARS-CoV-2 seropositivity in nursing home residents, Journal of Infection, Vol:82, ISSN:0163-4453, Pages:310-312
et al., 2021, Regular mass screening for SARS-CoV-2 infection in care homes already affected by COVID-19 outbreaks: Implications of false positive test results, Journal of Infection, Vol:82, ISSN:0163-4453, Pages:299-301
Duckworth H, Sharp DJ, Ghajari M, 2021, Smoothed particle hydrodynamic modelling of the cerebrospinal fluid for brain biomechanics: accuracy and stability, International Journal for Numerical Methods in Biomedical Engineering, ISSN:1069-8299